Commons Clinic Raises $26M in Series B Funding
Commons Clinic has made headlines with its recent announcement of securing $26 million in Series B financing, marking a significant milestone for the healthcare provider. The funding round was led by RA Capital and has propelled Commons Clinic’s total funding to over $60 million. This capital is primarily designated for launching
Wholebody, an innovative multi-specialty care platform.
The Wholebody program demonstrates Commons Clinic's commitment to advance integrated, physician-led care that is designed to be comprehensive and tailored to meet patients' diverse health needs. This new initiative aims to unify treatment across various specialties—including musculoskeletal, cardiovascular, women's health, metabolic, orthopedic, gastrointestinal health, chronic pain management, and preventive oncology—into an efficient and streamlined system.
According to Nick Aubin, co-founder and CEO of Commons Clinic, the existing model of specialty healthcare often falls short when it comes to early intervention. Patients typically receive specialized care only when conditions have escalated, leading to more severe health complications. Commons Clinic seeks to bridge this gap by focusing on timely access to expert specialists, actively targeting health risks, and implementing preventive measures before issues can develop further.
The Wholebody platform allows patients to benefit from advanced diagnostics to evaluate critical health indicators. This includes comprehensive screenings supported by the latest diagnostic technologies, which can effectively identify conditions that may lead to serious health issues. The program offers up to three specialty consults through Commons Clinic’s extensive national expert network and facilitates expedited access to primary care partners through a vetted “FastPass” network.
Through the Wholebody model, patients who need urgent attention—whether it’s understanding the implications of possessing the BRCA gene or addressing unacceptable levels of coronary plaque—will be swiftly connected to appropriate care. This not only improves patient outcomes but also ensures that they take actionable steps towards their health.
Inspired by leading healthcare institutions renowned for their specialized services such as the Mayo Clinic and MD Anderson, Commons Clinic is working to set new benchmarks in the field of specialty healthcare. Its model not only focuses on enhancing care quality but also on managing costs effectively, making it sustainable in the long term.
At the core of the Wholebody initiative is a team of specialists recognized for their innovative methods and comprehensive understanding of patient needs. As Ben Schwartz, MD, SVP of Care Services at Commons Clinic remarked, the organization’s initial success in musculoskeletal care provides a robust foundation for expanding its services into other specialty areas, including metabolic and cardiac health.
This integrated approach aims to empower patients to tackle complex health challenges with precision, thereby improving their overall health outcomes significantly. The success of Commons Clinic can also be underscored by its advancements in unique surgical techniques—showcased by Dr. Andrew Wassef's pioneering robotic hip replacement procedures—and ongoing research initiatives.
With Dr. Jenica Ortega, a board-certified cardiologist, at the helm of the Wholebody program, Commons Clinic is well-equipped to explore opportunities in cardiac, metabolic, and women's health areas effectively. The strategic insights offered by Brad Hively, former CEO of The Oncology Institute, will further guide the development of value-based care strategies that align with the organization’s mission.
For anyone interested in learning more about the Wholebody program or Commons Clinic's innovative approach to specialty care, additional information is available at
commonsclinic.com/wholebody.
In conclusion, Commons Clinic is not only reshaping the healthcare landscape by establishing a vertically integrated model for delivering specialty care but also ensuring that preventative services are at the forefront of patient care protocols. This substantial investment marks a pivotal point for the company as it endeavors to create a more proactive and integrated healthcare experience for patients across various specialties.